التفاصيل البيبلوغرافية
| العنوان: |
The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia. |
| المؤلفون: |
Mustoe, Mollie M, Lee, Carmen M, Melisko, Michelle E, Esserman, Laura J, Rugo, Hope S |
| المصدر: |
Future Oncology; Oct2108, Vol. 14 Issue 23, p2461-2469, 9p |
| مصطلحات موضوعية: |
ANTINEOPLASTIC agents, BALDNESS, INDUCED hypothermia, SCALP |
| مستخلص: |
Chemotherapy-induced alopecia remains an emotionally traumatic side effect for cancer patients that impacts the quality of life, may be protracted in duration and may influence treatment decisions. Scalp cooling has been shown to be effective in preventing chemotherapy-induced alopecia. The DigniCap Scalp Cooling System is designed to prevent hair loss by cooling the scalp to reduce the impact of chemotherapy on hair follicle cells. Recent studies have shown the safety, efficacy and low-grade toxicity of the DigniCap System with a 66.3% success rate in hair preservation (n = 106) relative to 0% in a nonrandomized control group according to a prospective pivotal study. Data also support improved quality of life in several domains. Two scalp cooling devices including the DigniCap are now US FDA cleared and can be offered as a part of standard of care. [ABSTRACT FROM AUTHOR] |
|
Copyright of Future Oncology is the property of Future Medicine Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
